KIM DONG (Chief Financial Officer) exercised options at UROGEN PHARMA LTD.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 9/12/2024ACC: 0001437749-24-029036
Officer· Chief Financial Officer
Since Mar 2022
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.50K acquired · 2.50K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+2.50K
Price / share
—
Trade value
—
% of position
7.1%
9/9/2024
35.25K→37.75K
Total
Net shares
+2.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/9/2024 | M · Option Exercise | +2.50K | — | — | 7.1% | 35.25K | 37.75K |
| Total | +2.50K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
2.50K shares
Shares
−2.50K
Strike price
Held after
5K
Exercisable
—
9/9/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares2.50K shares | 9/9/2024 | M · Option Exercise | −2.50K | — | 5K |